CVS Drug Benefits Managment Growth Pace Pleases Analysts By: Benzinga via Benzinga August 06, 2014 at 16:11 PM EDT CVS Caremark's (NYSE: CVS) second-quarter performance in its prescription benefits management segment drew plaudits from analysts ... Read More >> Related Stocks: CVS Health Corp